Avalo Therapeutics
Discovers, develops and commercializes neuroscience drugs. Learn more
Launch date
Employees
Market cap
€79.0m
Enterprise valuation
€79m (Public information from Sep 2024)
Share price
$9.371 CERC
Rockville Maryland (HQ)
Authorizing premium user...